Curing chronic hepatitis C--the arc of a medical triumph.
about
Treatment strategies for chronic hepatitis C prior to and following liver transplantationHost-Targeting Agents to Prevent and Cure Hepatitis C Virus InfectionNew treatment strategies for hepatitis C infectionHepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?Conditional Inducible Triple-Transgenic Mouse Model for Rapid Real-Time Detection of HCV NS3/4A Protease ActivitySupplementing Conventional Treatment with Pycnogenol® May Improve Hepatitis C Virus-Associated Type 2 Diabetes: A Mini ReviewInsights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic interventionEpidemiology of medications use in pregnancyRational Design and Adaptive Management of Combination Therapies for Hepatitis C Virus InfectionThe impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort StudyFuture of therapy for Hepatitis C in India: A Matter of Accessibility and Affordability?Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.A new HCV mouse model on the block.Future therapy of portal hypertension in liver cirrhosis - a guess.A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deteriorationSynergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C.Deconvoluting the composition of low-frequency hepatitis C viral quasispecies: comparison of genotypes and NS3 resistance-associated variants between HCV/HIV coinfected hemophiliacs and HCV monoinfected patients in Japan.Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.Results from a Geographically Focused, Community-Based HCV Screening, Linkage-to-Care and Patient Navigation ProgramHepatitis C virus-induced hepatocellular carcinomaNovel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb.One-Step Recovery of scFv Clones from High-Throughput Sequencing-Based Screening of Phage Display Libraries Challenged to Cells Expressing Native Claudin-1.Personalized management of hepatocellular carcinoma based on molecular information: future prospects.New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.Identification of a Potent and Broad-Spectrum Hepatitis C Virus Fusion Inhibitory Peptide from the E2 Stem DomainHepatitis C-related hepatocellular carcinoma in the era of new generation antivirals.Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients.Functional differences in hepatitis C virus nonstructural (NS) 3/4A- and 5A-specific T cell responsesHepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C VirusNative Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.Visualizing the Essential Role of Complete Virion Assembly Machinery in Efficient Hepatitis C Virus Cell-to-Cell Transmission by a Viral Infection-Activated Split-Intein-Mediated Reporter System.Clinical development of hepatitis C virus host-targeting agents.Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.Hepatitis C virus drug resistance-associated substitutions: State of the art summary.Development of sofosbuvir for the treatment of hepatitis C virus infection.Evidence for association between hepatitis C virus and Parkinson's disease.Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.
P2860
Q26771244-3DA61763-9399-4C8B-8896-158A6668396FQ26779128-1C84AB14-C02F-4F8A-99BC-6E87A70B1B9EQ26795407-57807EC5-CA1B-4AC3-8D16-90EFEB09416CQ26798469-03E85777-7DD7-4180-B65D-1C34E1F8FBD5Q27318504-ADDCE821-6F29-4347-A4A2-8282885E8506Q28068362-A5E06C97-DD49-49B5-BFE6-0BE391B6FCF9Q28080281-04D4D319-EE13-4C13-8271-15CECE984073Q28083692-E117452B-F48E-4CEE-80BE-82C3CA00C0E6Q28545971-179EC440-8C4F-4E82-8658-809D3AB418A0Q30250096-3FCCE2D0-EF4F-4D43-8E76-DF9E2B03CC00Q30386551-A4FD1FB2-1F86-46FF-89F6-BF4AA7E564A4Q31168033-B30756CA-6A49-4069-A6DE-F867E29652E4Q33978118-5782FF54-2800-4B10-BBC3-F1D9A62D414FQ34262175-3F24D966-7C62-484A-A39E-98FB9395A2B7Q34289919-FCA177E3-3300-4152-870D-D1B419DB3E2CQ34446521-FBACBB9C-2386-4FC4-88BC-A21E6FBE716FQ35107005-70BDE0D8-1302-47EF-835B-87260C365307Q35135565-FD27589B-C937-4560-B1FA-22183679E5BCQ35154587-952E139F-6585-44D4-8F0C-7876E6A3FF76Q35619104-3F0F913E-B9A9-4F27-8668-7B227FDBE581Q35752660-89881125-4F07-419B-B4EA-8F33FA241217Q35824057-F7A33608-EA79-425F-91F3-5660DA39A4ACQ35828072-FC1CFC7A-5CC6-4887-8FDA-24409871CB5FQ35863983-2D810DE0-22E2-4383-AF72-9E918DCEABADQ35881575-4BEAFF05-1D5A-467E-A2DF-DE600064C76FQ35914270-A050EB78-032B-4137-8A8B-22951AA23135Q36001172-C96A048E-3D1A-46B3-8EB1-54B6E31A350CQ36306768-68E86A5F-DB13-4C33-96BF-D594C20D8323Q36741778-9C47F3D6-2D02-4FB1-AE72-86A5EA0C6BF0Q36865009-224CB4BF-F9B6-42D2-AB5F-58EE0FA25BACQ37073281-DDF3D800-0A52-462E-B26E-3E909771D144Q37252935-DB2CC12F-40C2-4906-9DA8-79DF0AEE40E2Q37512845-D755A90C-C1AF-44A5-8A5D-4ADD879FE706Q37560723-CC585130-B81F-454D-B21B-4416BD7AD2E6Q37662513-82D370F9-29FD-43B8-BC0D-7EAD1DB90111Q38351585-16F919E1-9BF3-4346-8AC2-C05BC52E0529Q38533619-6F7CA036-4642-4C5D-A5E8-C0A5BB0F5598Q38559442-F1F81368-65DB-430D-9AF6-0DD5096E9EFFQ38638550-010B7753-6381-415F-A0ED-8E7D8D072A0AQ38726399-E0E6C7BB-ADCE-4486-BE29-71EEEBC1A074
P2860
Curing chronic hepatitis C--the arc of a medical triumph.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Curing chronic hepatitis C--the arc of a medical triumph.
@en
Curing chronic hepatitis C--the arc of a medical triumph.
@nl
type
label
Curing chronic hepatitis C--the arc of a medical triumph.
@en
Curing chronic hepatitis C--the arc of a medical triumph.
@nl
prefLabel
Curing chronic hepatitis C--the arc of a medical triumph.
@en
Curing chronic hepatitis C--the arc of a medical triumph.
@nl
P356
P1476
Curing chronic hepatitis C--the arc of a medical triumph.
@en
P2093
Thomas F Baumert
P304
P356
10.1056/NEJMP1400986
P407
P577
2014-04-10T00:00:00Z